A treatment with 50 μM of SB-431542 during 16 hours induced the relocalization of beta-catenin at the membrane of tumor cells, indicating that TGFRI activity neutralization can reverse EMT in NRP2 expressing colorectal cancer cells. The gene discussed is CTNNB1; the disease is neoplasm.